Latest filing published 11 Oct 2023 for T2 Biosystems, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
John W. Cumming: trading record in brief
John W. Cumming is a declared insider at 2 companies (board member); the most frequent names are Hologic Inc and T2 Biosystems, Inc. In total, 69 filings cover trades dated from 30 October 2006 to 15 September 2023.
In open-market terms, that means 4 purchases worth €665k on one side and 12 sales worth €31.0M on the other. Sales outweigh purchases by €30.3M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 31 share grants and 22 option exercises.
Half of the purchases are above €81k and half below.
The record was last updated on 11 October 2023 with an option exercise in T2 Biosystems, Inc. The clock since the last published purchase (8 August 2008) now reads 6,666 days. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to John W. Cumming
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,600 sharesCommon StockSEC:0000950170-23-052934:0
- 81,967 sharesCommon StockSEC:0000899243-22-024420:0
- 18,182 shares@ US$1.16100.0% of flowCommon StockSEC:0000899243-21-027183:0
- 45,454 sharesCommon StockSEC:0000899243-21-026536:0
- 3,420 shares@ US$1.430.0% of flowCommon StockSEC:0000899243-19-016821:0
- 9,000 sharesCommon StockSEC:0000899243-19-016450:0
- 18,000 sharesCommon StockSEC:0000899243-18-015115:0
- 1,024 shares@ US$21.11Common StockSEC:0001127602-13-031867:1
- 1,258 shares@ US$21.11Common StockSEC:0001127602-13-031867:2
- 411 shares@ US$21.11Common StockSEC:0001127602-13-031867:3
- 2,694 shares@ US$22.04Common StockSEC:0001127602-13-031270:0
- 1,253 shares@ US$22.04Common StockSEC:0001127602-13-031270:1
- 1,463 shares@ US$22.04Common StockSEC:0001127602-13-031270:2
- 475 shares@ US$22.04Common StockSEC:0001127602-13-031270:3
- 1,337 shares@ US$22.04Common StockSEC:0001127602-13-031270:4
- 436 shares@ US$22.04Common StockSEC:0001127602-13-031270:5
- 11,111 shares@ US$22.90Common StockSEC:0001127602-13-031270:6
- 5,165 shares@ US$22.90Common StockSEC:0001127602-13-031270:7
- 1,428 shares@ US$22.90Common StockSEC:0001127602-13-031270:8
- 466 shares@ US$22.90Common StockSEC:0001127602-13-031270:9
- 12,100 shares@ US$21.26Common StockSEC:0001417626-11-000032:0
- 70,449 shares@ US$21.37Common StockSEC:0001417626-11-000032:1
- 50,000 shares@ US$21.25Common StockSEC:0001417626-11-000028:0
- 29,344 shares@ US$19.17Common StockSEC:0001417626-11-000010:0
- 33,400 shares@ US$19.17Common StockSEC:0001417626-11-000010:1
25 of 67 declarations